Lisa Cook sues Trump over firing attempt, emergency hearing set
In a recent transaction involving agilon health , inc. (NYSE:AGL), Shaker (TADAWUL:1214) Benjamin, the company’s Chief Markets Officer, reported the disposition of common stock valued at $16,779. The shares were withheld by the issuer to meet tax obligations related to the net settlement of performance-based restricted stock units (PSUs). The transaction, dated March 14, 2025, involved 4,143 shares at $4.05 per share. The stock, which has shown remarkable strength with a 12.21% gain in the past week, currently trades at $4.32. InvestingPro analysis indicates the stock is trading near its Fair Value, with additional insights available in the comprehensive Pro Research Report.
On the same day, Benjamin acquired 11,786 shares of common stock through the vesting of PSUs. These awards were granted on April 14, 2022, and vested based on agilon health’s performance metrics, achieving 87% of the predetermined goals over a three-year period. Following these transactions, Benjamin holds a total of 457,058 shares, including restricted stock units. The company, currently valued at $1.79B, has demonstrated strong momentum with a year-to-date return of 127.37%. InvestingPro subscribers can access 10+ additional expert insights about AGL’s financial health and market position.
In other recent news, Agilon Health reported a mixed financial performance for the fourth quarter of 2024, with revenue reaching $1.52 billion, surpassing forecasts, but earnings per share (EPS) missing expectations at -$0.26 against a forecast of -$0.22. The company saw a 44% year-over-year revenue increase, attributed to growth in Medicare Advantage and ACO Model memberships. Truist Securities maintained a Hold rating on Agilon Health, adjusting its revenue projections for fiscal years 2025 and 2026 to $5.9 billion and $6.2 billion, respectively, down from previous estimates. Additionally, Benchmark analysts raised their price target for Agilon Health shares to $4.00, highlighting the company’s alignment with fourth-quarter expectations and a conservative outlook for 2025. Stifel also increased their price target to $3.00, noting a strategic shift toward profitability over growth for 2025. Agilon Health plans to exit two unprofitable physician partnerships and anticipates a 4% decrease in Medicare Advantage membership, while expecting to gain 20,000 new members through new partnerships. The company is focused on renegotiating payer contracts and reducing Medicare Part D exposure to enhance financial stability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.